Cypherpunk Technologies Inc. (5MC)
Munich
Closed
Aug 24, 2026
Day's Range
1.5152 wk Range
0.2400Overview - 5MC - Cypherpunk Technologies Inc.
Key Statistics
Valuation
P/E (Trailing)
‪21.64‬
PEG Ratio
‪0.88‬
Price / Book
‪3.01‬
Profitability
Return on Assets
‪2.95%‬
Return on Equity
‪3.14%‬
Ownership
Shares Outstanding
93.92M
Price stats
50-Day Avg
‪0.6192‬
200-Day Avg
‪0.8181‬
Peers - 5MC - Cypherpunk Technologies Inc.
Peer Comparison
Compared with companies in Asset Management listed on Munich.
- 5MCMunichCypherpunk Technologies Inc.+76.79%52-week change15.14P/E (Trailing)—Profit Margin
- EOIMunichEco Atlantic Oil & Gas Ltd.+82.79%52-week change-25.22P/E (Trailing)—Profit Margin
- 5H5AMunichHBM Healthcare Investments AG+62.30%52-week change6.30P/E (Trailing)—Profit Margin
- 0BMMunichRTW Biotech Opportunities Ltd+51.74%52-week change—P/E (Trailing)—Profit Margin
- BBDCMunichBombardier Inc.+51.55%52-week change23.09P/E (Trailing)‪20.00%‬Profit Margin
- A781MunichSprott Inc.+48.69%52-week change41.07P/E (Trailing)‪37.37%‬Profit Margin
- GRWMunichMolten Ventures plc+47.50%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - 5MC - Cypherpunk Technologies Inc.
About
Cypherpunk Technologies Inc. is a biopharmaceutical company focused on developing novel antibody therapies for cancer treatment, with a strategic emphasis on biomarker-targeted approaches. The company’s lead clinical-stage candidate, DKN-01, is a monoclonal antibody designed to inhibit Dickkopf-related protein 1 and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
